country,alpha_2_code,alpha_3_code,numeric_code,indicator,time_period,obs_value,sex,unit_multiplier,unit_of_measure,observation_status,observation_confidentaility,time_period_activity_related_to_when_the_data_are_collected,current_age
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1997,16,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1998,24,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1999,32,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,29,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,25,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,25,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,31,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,39,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,23,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,22,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,51,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,39,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,17,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,16,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,38,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,36,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,21,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,48,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,43,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,24,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,28,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,45,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,45,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,30,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,31,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,20,Total,Units,%,Estimated value,,,12 to 23 months old
Angola,AO,AGO,24,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,42,Total,Units,%,Estimated value,,,12 to 23 months old
Argentina,AR,ARG,32,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,7,Total,Units,%,Estimated value,,,2 years old
Argentina,AR,ARG,32,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,5,Total,Units,%,Estimated value,,,2 years old
Argentina,AR,ARG,32,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,6,Total,Units,%,Estimated value,,,2 years old
Argentina,AR,ARG,32,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,6,Total,Units,%,Estimated value,,,2 years old
Argentina,AR,ARG,32,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,7,Total,Units,%,Estimated value,,,2 years old
Argentina,AR,ARG,32,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,8,Total,Units,%,Estimated value,,,2 years old
Argentina,AR,ARG,32,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,8,Total,Units,%,Estimated value,,,2 years old
Argentina,AR,ARG,32,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,6,Total,Units,%,Estimated value,,,2 years old
Argentina,AR,ARG,32,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,8,Total,Units,%,Estimated value,,,2 years old
Argentina,AR,ARG,32,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,7,Total,Units,%,Estimated value,,,2 years old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,27,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,65,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,65,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,61,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,67,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,70,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,66,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,72,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,68,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,69,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,69,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,70,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,63,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,63,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,64,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,62,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,61,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,59,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,57,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,56,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,55,Total,Units,%,Estimated value,,,12 to 23 months old
Benin,BJ,BEN,204,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,55,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,23,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,84,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,87,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,93,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,88,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,72,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,74,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,92,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,90,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,83,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,73,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,88,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,89,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,82,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,84,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,77,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,72,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,71,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,67,Total,Units,%,Estimated value,,,12 to 23 months old
"Bolivia, Plurinational State of",BO,BOL,68,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,67,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1998,38,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1999,38,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,37,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,39,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,20,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,34,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,31,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,34,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,34,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,36,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,35,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,34,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,34,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,37,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,42,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,45,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,47,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,46,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,43,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,44,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,58,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,60,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,57,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,58,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,61,Total,Units,%,Estimated value,,,12 to 23 months old
Brazil,BR,BRA,76,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,70,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1999,17,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,40,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,36,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,45,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,60,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,71,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,84,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,88,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,89,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,91,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,93,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,82,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,82,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,87,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,88,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,88,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,88,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,49,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,47,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,85,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,85,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,85,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,85,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,91,Total,Units,%,Estimated value,,,12 to 23 months old
Burkina Faso,BF,BFA,854,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,94,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,59,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,68,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,72,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,74,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,77,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,72,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,79,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,76,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,74,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,71,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,70,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,69,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,72,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,68,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,64,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,62,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,62,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,61,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,64,Total,Units,%,Estimated value,,,12 to 23 months old
Cameroon,CM,CMR,120,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,67,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1997,42,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1998,41,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1999,37,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,36,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,35,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,42,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,48,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,55,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,62,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,62,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,62,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,62,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,62,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,55,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,48,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,48,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,24,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,47,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,47,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,46,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,41,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,41,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,41,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,41,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,41,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,41,Total,Units,%,Estimated value,,,12 to 23 months old
Central African Republic,CF,CAF,140,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,41,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1997,13,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1998,13,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1999,31,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,28,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,26,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,23,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,20,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,24,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,33,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,40,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,39,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,33,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,32,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,41,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,45,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,51,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,44,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,34,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,41,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,29,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,29,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,35,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,36,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,37,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,48,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,46,Total,Units,%,Estimated value,,,12 to 23 months old
Chad,TD,TCD,148,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,62,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,88,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,84,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,81,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,80,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,79,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,88,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,92,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,92,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,92,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,85,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,77,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,88,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,87,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,90,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,84,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,86,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,75,Total,Units,%,Estimated value,,,12 to 23 months old
Colombia,CO,COL,170,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,86,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,48,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,54,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,66,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,63,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,67,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,66,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,75,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,74,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,62,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,80,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,80,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,80,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,59,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,63,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,66,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,71,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,69,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,67,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,61,Total,Units,%,Estimated value,,,12 to 23 months old
Congo,CG,COG,178,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,61,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1997,59,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1998,57,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1999,48,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,60,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,67,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,67,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,65,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,73,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,83,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,67,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,68,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,50,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,24,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,64,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,49,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,73,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,61,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,52,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,54,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,62,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,68,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,73,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,70,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,64,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,65,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,60,Total,Units,%,Estimated value,,,12 to 23 months old
Ivory Coast,CI,CIV,384,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,67,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,5,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,25,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,42,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,50,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,54,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,59,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,63,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,60,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,44,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,63,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,54,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,56,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,64,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,56,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,62,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,65,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,65,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,63,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,56,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,55,Total,Units,%,Estimated value,,,12 to 23 months old
"Congo, the Democratic Republic of the",CD,COD,180,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,50,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,5,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,5,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,5,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,5,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,5,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,5,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,5,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,5,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,5,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,5,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,81,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,74,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,74,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,73,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,86,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,78,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,81,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,84,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,85,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,84,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,79,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,70,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,70,Total,Units,%,Estimated value,,,12 to 23 months old
Ecuador,EC,ECU,218,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,70,Total,Units,%,Estimated value,,,12 to 23 months old
Equatorial Guinea,GQ,GNQ,226,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,2,Total,Units,%,Estimated value,,,12 to 23 months old
Equatorial Guinea,GQ,GNQ,226,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,52,Total,Units,%,Estimated value,,,12 to 23 months old
Equatorial Guinea,GQ,GNQ,226,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,51,Total,Units,%,Estimated value,,,12 to 23 months old
Equatorial Guinea,GQ,GNQ,226,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,50,Total,Units,%,Estimated value,,,12 to 23 months old
Equatorial Guinea,GQ,GNQ,226,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,53,Total,Units,%,Estimated value,,,12 to 23 months old
Equatorial Guinea,GQ,GNQ,226,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,49,Total,Units,%,Estimated value,,,12 to 23 months old
Equatorial Guinea,GQ,GNQ,226,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,59,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,15,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,28,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,42,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,55,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,65,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,70,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,67,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,61,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,71,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,71,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,69,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,60,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,68,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,64,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,63,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,59,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,61,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,52,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,64,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,51,Total,Units,%,Estimated value,,,12 to 23 months old
Gabon,GA,GAB,266,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,62,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1997,87,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1998,86,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1999,86,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,85,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,84,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,85,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,84,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,84,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,91,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,89,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,88,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,95,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,96,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,92,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,91,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,95,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,97,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,96,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,97,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,84,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,90,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,91,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,87,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,83,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,78,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,73,Total,Units,%,Estimated value,,,12 to 23 months old
Gambia,GM,GMB,270,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,78,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1997,40,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1998,50,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1999,60,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,74,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,87,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,82,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,77,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,81,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,82,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,84,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,94,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,86,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,93,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,93,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,91,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,88,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,87,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,92,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,88,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,88,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,86,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,91,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,92,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,88,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,94,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,95,Total,Units,%,Estimated value,,,12 to 23 months old
Ghana,GH,GHA,288,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,88,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,17,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,28,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,39,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,39,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,38,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,45,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,47,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,52,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,56,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,62,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,56,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,51,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,45,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,44,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,40,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,40,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,40,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,40,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,40,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,40,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,40,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea,GN,GIN,324,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,40,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,37,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,69,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,74,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,78,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,75,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,75,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,53,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,75,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,80,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,72,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,80,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,79,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,71,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,63,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,71,Total,Units,%,Estimated value,,,12 to 23 months old
Guinea-Bissau,GW,GNB,624,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,70,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1998,7,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1999,45,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,83,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,90,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,90,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,89,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,89,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,91,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,90,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,96,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,97,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,97,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,94,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,97,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,99,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,99,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,99,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,99,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,99,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,99,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,96,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,94,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,95,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,94,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,94,Total,Units,%,Estimated value,,,12 to 23 months old
Guyana,GY,GUY,328,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,94,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,2,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,2,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,1,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,2,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,7,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,7,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,4,Total,Units,%,Estimated value,,,12 to 23 months old
Kenya,KE,KEN,404,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,6,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,56,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,39,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,28,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,34,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,58,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,57,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,64,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,74,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,83,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,64,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,70,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,78,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,73,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,54,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,56,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,64,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,72,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,70,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,65,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,49,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,65,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,78,Total,Units,%,Estimated value,,,12 to 23 months old
Liberia,LR,LBR,430,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,82,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1998,10,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1999,13,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,11,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,8,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,28,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,57,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,62,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,72,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,72,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,71,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,74,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,72,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,69,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,66,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,63,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,60,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,59,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,63,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,68,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,66,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,65,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,65,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,58,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,64,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,64,Total,Units,%,Estimated value,,,12 to 23 months old
Mali,ML,MLI,466,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,64,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,10,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,15,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,21,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,26,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,32,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,37,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,32,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,37,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,47,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,67,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,64,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,52,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,73,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,75,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,79,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,84,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,76,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,82,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,78,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,83,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,67,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,80,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,80,Total,Units,%,Estimated value,,,12 to 23 months old
Niger,NE,NER,562,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,80,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,21,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,36,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,44,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,51,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,50,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,69,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,50,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,38,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,24,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,47,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,41,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,42,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,47,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,54,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,56,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,57,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,59,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,59,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,59,Total,Units,%,Estimated value,,,12 to 23 months old
Nigeria,NG,NGA,566,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,59,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1997,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1998,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1999,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,0,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,5,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,4,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,5,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,5,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,6,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,6,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,6,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,7,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,5,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,5,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,6,Total,Units,%,Estimated value,,,12 to 23 months old
Panama,PA,PAN,591,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,4,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,76,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,86,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,86,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,87,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,97,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,85,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,93,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,99,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,99,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,99,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,92,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,87,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,74,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,76,Total,Units,%,Estimated value,,,12 to 23 months old
Paraguay,PY,PRY,600,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,79,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,8,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,26,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,36,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,47,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,57,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,78,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,91,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,87,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,82,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,66,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,55,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,51,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,59,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,64,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,65,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,67,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,65,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,62,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,60,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,57,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,50,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,61,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,52,Total,Units,%,Estimated value,,,12 to 23 months old
Peru,PE,PER,604,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,61,Total,Units,%,Estimated value,,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,34,Total,Units,%,Estimated value,,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,51,Total,Units,%,Estimated value,,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,68,Total,Units,%,Estimated value,,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,85,Total,Units,%,Estimated value,,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,86,Total,Units,%,Estimated value,,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,94,Total,Units,%,Estimated value,,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,90,Total,Units,%,Estimated value,,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,92,Total,Units,%,Estimated value,,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,91,Total,Units,%,Estimated value,,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,92,Total,Units,%,Estimated value,,,12 to 23 months old
Sao Tome and Principe,ST,STP,678,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,91,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1998,50,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1999,43,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,34,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,34,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,53,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,59,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,75,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,75,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,80,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,86,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,81,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,76,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,80,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,84,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,80,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,83,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,80,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,80,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,77,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,79,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,79,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,79,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,80,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,76,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,76,Total,Units,%,Estimated value,,,12 to 23 months old
Senegal,SN,SEN,686,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,76,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,60,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,62,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,64,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,63,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,61,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,60,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,64,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,80,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,82,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,83,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,85,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,85,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,80,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,78,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,80,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,80,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,85,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,90,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,86,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,85,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,73,Total,Units,%,Estimated value,,,12 to 23 months old
Sierra Leone,SL,SLE,694,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,85,Total,Units,%,Estimated value,,,12 to 23 months old
Sudan,SD,SDN,736,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,39,Total,Units,%,Estimated value,,,12 to 23 months old
Sudan,SD,SDN,736,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,45,Total,Units,%,Estimated value,,,12 to 23 months old
Sudan,SD,SDN,736,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,50,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,18,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,14,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,12,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,11,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,11,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,11,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,10,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,55,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,58,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,61,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,68,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,61,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,67,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,63,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,57,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,44,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,61,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,76,Total,Units,%,Estimated value,,,12 to 23 months old
Suriname,SR,SUR,740,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,75,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,1,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,56,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,76,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,67,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,63,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,64,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,67,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,72,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,72,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,72,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,75,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,71,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,68,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,73,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,68,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,75,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,69,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,70,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,71,Total,Units,%,Estimated value,,,12 to 23 months old
Togo,TG,TGO,768,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,72,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1998,91,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),1999,91,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,91,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,91,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,88,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,88,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,90,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,93,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,88,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,90,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,86,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,94,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,95,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,95,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,85,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,89,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,96,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,91,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,85,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,95,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,88,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,98,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,89,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,91,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,93,Total,Units,%,Estimated value,,,12 to 23 months old
Trinidad and Tobago,TT,TTO,780,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,90,Total,Units,%,Estimated value,,,12 to 23 months old
Uganda,UG,UGA,800,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,4,Total,Units,%,Estimated value,,,12 to 23 months old
Uganda,UG,UGA,800,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,39,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2000,17,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2001,28,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2002,27,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2003,82,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2004,94,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2005,94,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2006,73,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2007,65,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2008,77,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2009,77,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2010,48,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2011,73,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2012,87,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2013,85,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2014,82,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2015,85,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2016,84,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2017,83,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2018,35,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2019,80,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2020,82,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2021,75,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2022,47,Total,Units,%,Estimated value,,,12 to 23 months old
"Venezuela, Bolivarian Republic of",VE,VEN,862,Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),2023,56,Total,Units,%,Estimated value,,,12 to 23 months old
